Skip to main content

Table 4 Association between outcomes and substance use group

From: No difference in COVID-19 treatment outcomes among current methamphetamine, cannabis and alcohol users

 

Group

  

METH (N = 32) n (%)

Cannabis (N = 46)

n (%)

Alcohol (N = 44) n (%)

Total (N = 122) n (%)

P-value

ICU LOS (in days)

    

0.34711

 N (Missing)

7 (25)

7 (39)

9 (35)

23 (99)

 

 Mean (SD)

3.9 (6.69)

6.9 (11.28)

2.0 (1.73)

4.0 (7.23)

 

 Median

1

2

1

1

 

 IQR

1.0, 2.0

1.0, 7.0

1.0, 3.0

1.0, 3.0

 

 Range

1.0, 19.0

1.0, 32.0

1.0, 6.0

1.0, 32.0

 

Interval between positive COVID and discharge (in days)

    

0.01671

 N (Not applicable)

23 (9)

27 (19)

44 (0)

94 (28)

 

 Mean (SD)

5.9 (6.34)

9.4 (9.20)

4.7 (4.65)

6.3 (6.87)

 

 Median

4

7

3

4

 

 IQR

2.0, 6.0

3.0, 13.0

1.0, 6.0

2.0, 7.0

 

 Range

1.0, 22.0

1.0, 40.0

1.0, 19.0

1.0, 40.0

 

Admitted to ICU

7 (21.9%)

7 (15.2%)

9 (20.5%)

23 (18.9%)

0.71812

Intubation Required

5 (15.6%)

4 (8.7%)

4 (9.1%)

13 (10.7%)

0.56872

Delirium

12 (37.5%)

11 (23.9%)

13 (29.5%)

36 (29.5%)

0.43282

Deceased

2 (6.3%)

2 (4.3%)

4 (9.1%)

8 (6.6%)

0.65962

  1. ICU Intensive Care Unit, SD Standard deviation, IQR Inter-quartile range
  2. 1Kruskal-Wallis p-value; 2Chi-Square p-value